Denna sida på svenska

Kristin Feltmann

Graduate Student

Visiting address : Norra Stationsgatan 69, Plan 7 113 64 Stockholm, Sweden
Postal address : Department of Clinical Neuroscience (CNS), K8, CPF Steensland, Norra Stationsgatan 69, Plan 7 113 64 Stockholm, Sweden
Delivery address : Norra Stationsgatan 69, Plan 7 113 64 Stockholm, Sweden

About me

I am a PhD student under the supervision of Dr. Pia Steensland. Our aim is to identify potential novel treatments for alcohol use disorder using translational research. The compound (-)-OSU6162 seemed very promising as a potential medication based on its effects on alcohol-related behaviors. During my PhD I investigate the underlying neurochemical mechanisms of this compound and evaluate its potential as a treatment for eating disorders. Moreover, I study molecular changes in the brain induced by long-term alcohol drinking. Previously, I also researched on other psychiatric disorders including depression, Parkinson's Disorder and Schizophrenia. Although I find research, especially in psychiatry, highly interesting I am also open to new opportunities after my defence in 2017. 

Education

Master Biomedicine, Karolinska Institutet

Documents

Publications

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study
Marcus Mm, Björkholm C, Malmerfelt A, Möller A, Påhlsson N, Konradsson-geuken Å, et al
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2016;26(9):1401-11

The monoamine stabilizer (-)-OSU6162 counteracts downregulated dopamine output in the nucleus accumbens of long-term drinking Wistar rats
Feltmann K, Fredriksson I, Wirf M, Schilström B, Steensland P
Addiction biology 2016;21(2):438-49

Antidepressant drugs specifically inhibiting noradrenaline reuptake enhance recognition memory in rats
Feltmann K, Konradsson-geuken Å, De Bundel D, Lindskog M, Schilström B
Behavioral neuroscience 2015;129(6):701-8

Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor
Malmlöf T, Feltmann K, Konradsson-geuken Å, Schneider F, Alken Rg, Svensson Th, et al
Journal of neural transmission (Vienna, Austria : 1996) 2015;122(2):259-72

Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine
De Bundel D, Femenía T, Dupont Cm, Konradsson-geuken Å, Feltmann K, Schilström B, et al
The international journal of neuropsychopharmacology 2013;16(9):2041-51

The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
Egecioglu E, Steensland P, Fredriksson I, Feltmann K, Engel Ja, Jerlhag E
Psychoneuroendocrinology 2013;38(8):1259-70

Dopamine in the hippocampus is cleared by the norepinephrine transporter
Borgkvist A, Malmlöf T, Feltmann K, Lindskog M, Schilström B
The international journal of neuropsychopharmacology 2012;15(4):531-40

The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens
Steensland P, Fredriksson I, Holst S, Feltmann K, Franck J, Schilström B, et al
Biological psychiatry 2012;72(10):823-31

Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat
Schilström B, Konradsson-geuken A, Ivanov V, Gertow J, Feltmann K, Marcus Mm, et al
Synapse (New York, N.Y.) 2011;65(5):357-67

Map